Borderline ovarian tumour

Exam relevance: in 5 of 197 board exam reports · rank 101

Specialty
Gynaecology · Ovary & adnexa
Images
Ultrasound 2
Exam relevance
5 of 197 reports · rank 101
In the app
1 flashcards · GynFuchs
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (2)
  2. Definition
  3. Classification
  4. Occurrence & epidemiology
  5. Aetiopathogenesis
  6. Diagnosis
  7. Keep learning in the app
  8. Further reading (selection)
  9. Cross-references

Images (2)

Borderline ovarian tumour – Ultrasound: Transvaginal ultrasound: unilocular-solid cyst with a papillary projection, Colour Score 3 — histologically a seromucinous borderline tumourUltrasound
Transvaginal ultrasound: unilocular-solid cyst with a papillary projection, Colour Score 3 — histologically a seromucinous borderline tumourImage: Moro F. et al., Acta Obstet Gynecol Scand 2026 (PMC13395054) · CC BY 4.0 · Source · cropped
Borderline ovarian tumour – Ultrasound: Transvaginal ultrasound: unilocular cyst with a large solid papillary projection (next to it an endometrioma)Ultrasound
Transvaginal ultrasound: unilocular cyst with a large solid papillary projection (next to it an endometrioma)Image: Moro F. et al., Acta Obstet Gynecol Scand 2026 (PMC13395054) · CC BY 4.0 · Source · cropped
1 / 2

Definition

  • Definition: A borderline tumour is an epithelial tumour with cellular atypia and proliferation, but without destructive stromal invasion.
  • Patient population: It often affects significantly younger women than invasive carcinoma, often with a desire to have children.
  • Ultrasound: On ultrasound, it is often noted for papillary projections in an otherwise unilocular cyst.
  • Borderline ovarian tumours are epithelial tumours whose behaviour lies between benign tumours and invasive carcinomas.
  • They show no destructive stromal invasion, which distinguishes them from other ovarian neoplasms.

Classification

Staging

  • Mucinous subtype: For a mucinous borderline tumour, infracolic omentectomy and assessment of the appendix is added.
  • The commonest subtypes are serous (about 50%) and mucinous (about 45%); endometrioid, clear cell, seromucinous and Brenner borderline tumours are rarer.
  • Despite the absence of stromal invasion, microinvasion, lymph node involvement and non-invasive or invasive peritoneal implants may occur.

Occurrence & epidemiology

Epidemiology

  • They occur in 1.8–4.8 per 100,000 women per year and make up 10–20% of epithelial ovarian tumours; women of reproductive age are frequently affected.

Aetiopathogenesis

Pathogenesis

  • Molecularly, borderline tumours resemble low-grade serous carcinomas; in some cases a gradual progression from cystadenoma through borderline tumour to low-grade serous carcinoma has been observed.
  • The BRAF V600E mutation is found in up to 40% of serous borderline tumours.

Diagnosis

  • Before histological confirmation, assessment relies on markers such as CA 125, HE4 and the ROMA algorithm; imaging and tumour markers alone cannot reliably distinguish a borderline tumour from early ovarian carcinoma.
  • The diagnosis is histological; frozen section is less accurate for borderline tumours than for benign or malignant tumours, and particularly in bulky tumours microinvasion or intraepithelial carcinoma may be missed.

Keep learning in the app

In the GynFuchs app you can learn Borderline ovarian tumour with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 1 flashcards on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. Molecular landscape of borderline ovarian tumours: A systematic review (Open Med (Wars) 2024, PubMed Central)
  2. Serous Borderline Ovarian Tumor Diagnosis … in Young Women (J Clin Med 2021, PubMed Central)
  3. DocCheck Flexikon, Borderline-Tumor

Cross-references

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.